These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 26187408)
1. Macular auto-fluorescence is a follow-up parameter for cystoids macular edema. Zhang X; Gong X; Wang Y; Wang N Sci China Life Sci; 2015 Aug; 58(8):773-7. PubMed ID: 26187408 [TBL] [Abstract][Full Text] [Related]
2. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study. Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142 [TBL] [Abstract][Full Text] [Related]
3. Macular autofluorescence in eyes with cystoid macula edema, detected with 488 nm-excitation but not with 580 nm-excitation. Bessho K; Gomi F; Harino S; Sawa M; Sayanagi K; Tsujikawa M; Tano Y Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):729-34. PubMed ID: 19184082 [TBL] [Abstract][Full Text] [Related]
4. Anatomical and visual outcomes of ranibizumab injections in retinal pigment epithelium tears. Erol MK; Ozdemir O; Coban DT; Ceran BB; Sari ES Arq Bras Oftalmol; 2015; 78(3):168-72. PubMed ID: 26222106 [TBL] [Abstract][Full Text] [Related]
5. Intravitreal injection of ranibizumab for recovery of macular function in eyes with subfoveal polypoidal choroidal vasculopathy. Ogino K; Tsujikawa A; Yamashiro K; Ooto S; Oishi A; Nakata I; Miyake M; Yoshimura N Invest Ophthalmol Vis Sci; 2013 May; 54(5):3771-9. PubMed ID: 23661367 [TBL] [Abstract][Full Text] [Related]
6. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment. Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578 [TBL] [Abstract][Full Text] [Related]
7. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710 [TBL] [Abstract][Full Text] [Related]
8. The discrepancy between central foveal thickness and best corrected visual acuity in cystoid macular edema secondary to central retinal vein occlusion after intravitreal lucentis® injection. Hua R; Li C; Hu Y; Chen L Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):310-3. PubMed ID: 25818575 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal Ranibizumab for the Treatment of Irvine-Gass Syndrome. Mitropoulos PG; Chatziralli IP; Peponis VG; Drakos E; Parikakis EA Ocul Immunol Inflamm; 2015 Jun; 23(3):225-31. PubMed ID: 24678790 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A Retina; 2006; 26(9):999-1005. PubMed ID: 17151486 [TBL] [Abstract][Full Text] [Related]
11. [Measurement of macular edema in retinal vein occlusion using optical coherence tomography and its visual prognosis]. Zhang HR; Wang X; Lu XR; Yang YF; Liu F Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):910-6. PubMed ID: 16271177 [TBL] [Abstract][Full Text] [Related]
12. Bilateral effect of unilateral ranibizumab in patients with uveitis-related macular edema. Acharya NR; Sittivarakul W; Qian Y; Hong KC; Lee SM Retina; 2011 Oct; 31(9):1871-6. PubMed ID: 21716165 [TBL] [Abstract][Full Text] [Related]
13. Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography. Markomichelakis NN; Halkiadakis I; Pantelia E; Peponis V; Patelis A; Theodossiadis P; Theodossiadis G Ophthalmology; 2004 May; 111(5):946-53. PubMed ID: 15121373 [TBL] [Abstract][Full Text] [Related]
14. Ranibizumab for refractory uveitis-related macular edema. Acharya NR; Hong KC; Lee SM Am J Ophthalmol; 2009 Aug; 148(2):303-309.e2. PubMed ID: 19427988 [TBL] [Abstract][Full Text] [Related]
15. Spectral-Domain OCT Analyses of Macular Changes After Ranibizumab Therapy for Type 1 Retinopathy of Prematurity. Erol MK; Coban DT; Özdemir Ö; Tunay ZÖ; Bilgin AB; Dogan B J Pediatr Ophthalmol Strabismus; 2015; 52(3):152-8. PubMed ID: 25859685 [TBL] [Abstract][Full Text] [Related]
16. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study. Grenga P; Lupo S; Domanico D; Vingolo EM Retina; 2008 Oct; 28(9):1270-5. PubMed ID: 18664938 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal ranibizumab for the treatment of cystoid macular edema in Irvine-Gass syndrome. Demirel S; Batioğlu F; Özmert E J Ocul Pharmacol Ther; 2012 Dec; 28(6):636-9. PubMed ID: 22731243 [TBL] [Abstract][Full Text] [Related]
19. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration]. Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687 [TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab (avastin) in the treatment of macular edema associated with perfused retinal vein occlusion. Hung KH; Lee SM; Lee SY; Lee FL; Yang CS J Ocul Pharmacol Ther; 2010 Feb; 26(1):85-90. PubMed ID: 20148661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]